Cargando…

Angiotensin II-Induced Signal Transduction Mechanisms for Cardiac Hypertrophy

Although acute exposure of the heart to angiotensin (Ang II) produces physiological cardiac hypertrophy and chronic exposure results in pathological hypertrophy, the signal transduction mechanisms for these effects are of complex nature. It is now evident that the hypertrophic response is mediated b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhullar, Sukhwinder K., Dhalla, Naranjan S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657342/ https://www.ncbi.nlm.nih.gov/pubmed/36359731 http://dx.doi.org/10.3390/cells11213336

Ejemplares similares

Oxidative Stress as A Mechanism for Functional Alterations in Cardiac Hypertrophy and Heart Failure
por: Shah, Anureet K., et al.
Publicado: (2021)

Status of Mitochondrial Oxidative Phosphorylation during the Development of Heart Failure
por: Bhullar, Sukhwinder K., et al.
Publicado: (2023)

CD38 promotes angiotensin II‐induced cardiac hypertrophy
por: Guan, Xiao‐Hui, et al.
Publicado: (2017)

TNF-α-mediated signal transduction pathway is a major determinant of apoptosis in dilated cardiomyopathy
por: Das, Samarjit, et al.
Publicado: (2010)

Upregulation of Phospholipase C Gene Expression Due to Norepinephrine-Induced Hypertrophic Response
por: Tappia, Paramjit S., et al.
Publicado: (2022)

Novel EGFR inhibitors attenuate cardiac hypertrophy induced by angiotensin II
por: Peng, Kesong, et al.
Publicado: (2016)

Effect of endostatin overexpression on angiotensin II-induced cardiac hypertrophy in rats
por: Dai, You-Jin, et al.
Publicado: (2019)

Paeonol improves angiotensin II-induced cardiac hypertrophy by suppressing ferroptosis
por: Liu, Canzhang, et al.
Publicado: (2023)

Role of Oxidative Stress in Cardiac Dysfunction and Subcellular Defects Due to Ischemia-Reperfusion Injury
por: Dhalla, Naranjan S., et al.
Publicado: (2022)

The orphan receptor TR3 participates in angiotensin II-induced cardiac hypertrophy by controlling mTOR signalling
por: Wang, Rong-Hao, et al.
Publicado: (2013)

β-catenin/LEF1/IGF-IIR Signaling Axis Galvanizes the Angiotensin-II- induced Cardiac Hypertrophy
por: Lai, Chin-Hu, et al.
Publicado: (2019)

Stretch-Induced Biased Signaling in Angiotensin II Type 1 and Apelin Receptors for the Mediation of Cardiac Contractility and Hypertrophy
por: Seo, Kinya, et al.
Publicado: (2020)

Modification of Ischemia/Reperfusion-Induced Alterations in Subcellular Organelles by Ischemic Preconditioning
por: Tappia, Paramjit S., et al.
Publicado: (2022)

Upregulation of M(3) muscarinic receptor inhibits cardiac hypertrophy induced by angiotensin II
por: Liu, Yan, et al.
Publicado: (2013)

Angiotensin II-induced cardiac hypertrophy and fibrosis are promoted in mice lacking Fgf16
por: Matsumoto, Emi, et al.
Publicado: (2013)

Effect of the Shensong Yangxin Capsule on Energy Metabolism in Angiotensin II-Induced Cardiac Hypertrophy
por: Liu, Bei-Lei, et al.
Publicado: (2018)

Transmembrane protein 117 knockdown protects against angiotensin-II-induced cardiac hypertrophy
por: Yang, Yi, et al.
Publicado: (2023)

Mechanisms of the Beneficial Actions of Ischemic Preconditioning on Subcellular Remodeling in Ischemic-Reperfused Heart
por: Müller, By Alison L, et al.
Publicado: (2010)

Protein Kinases as Drug Development Targets for Heart Disease Therapy
por: Dhalla, Naranjan S., et al.
Publicado: (2010)

Mechanisms of the lysophosphatidic acid-induced increase in [Ca(2+)](i) in skeletal muscle cells
por: Xu, Yan-Jun, et al.
Publicado: (2008)

Anti-Interleukin-22-Neutralizing Antibody Attenuates Angiotensin II-Induced Cardiac Hypertrophy in Mice
por: Ye, Jing, et al.
Publicado: (2017)

Placental extract suppresses cardiac hypertrophy and fibrosis in an angiotensin II-induced cachexia model in mice
por: Yamauchi, Akihiro, et al.
Publicado: (2019)

Melatonin alleviates angiotensin-II-induced cardiac hypertrophy via activating MICU1 pathway
por: Yang, Yi, et al.
Publicado: (2020)

Role of Oxidative Stress in the Genesis of Ventricular Arrhythmias
por: Adameova, Adriana, et al.
Publicado: (2020)

Role of Oxidative Stress in Metabolic and Subcellular Abnormalities in Diabetic Cardiomyopathy
por: Dhalla, Naranjan S., et al.
Publicado: (2020)

Signal Transduction of Mineralocorticoid and Angiotensin II Receptors in the Central Control of Sodium Appetite: A Narrative Review
por: Iovino, Michele, et al.
Publicado: (2021)

β-adrenergic blockade attenuates cardiac dysfunction and myofibrillar remodelling in congestive heart failure
por: Machackova, Jarmila, et al.
Publicado: (2011)

Rutaecarpine Ameliorates Pressure Overload Cardiac Hypertrophy by Suppression of Calcineurin and Angiotensin II
por: Li, Shujun, et al.
Publicado: (2021)

Herpud1 suppress angiotensin II induced hypertrophy in cardiomyocytes
por: Mikawa, Mei, et al.
Publicado: (2022)

Effect of SKF-96365 on cardiomyocyte hypertrophy induced by angiotensin II
por: Cheng, Huijun, et al.
Publicado: (2020)

Augmented sphingosine 1 phosphate receptor-1 signaling in cardiac fibroblasts induces cardiac hypertrophy and fibrosis through angiotensin II and interleukin-6
por: Ohkura, Sei-ichiro, et al.
Publicado: (2017)

Mice lacking the Cβ subunit of PKA are resistant to angiotensin II-induced cardiac hypertrophy and dysfunction
por: Enns, Linda C, et al.
Publicado: (2010)

Concerted Regulation of cGMP and cAMP Phosphodiesterases in Early Cardiac Hypertrophy Induced by Angiotensin II
por: Mokni, Walid, et al.
Publicado: (2010)

Erratum to “Anti-Interleukin-22-Neutralizing Antibody Attenuates Angiotensin II-Induced Cardiac Hypertrophy in Mice”
por: Ye, Jing, et al.
Publicado: (2018)

DIOL Triterpenes Block Profibrotic Effects of Angiotensin II and Protect from Cardiac Hypertrophy
por: Martín, Ruben, et al.
Publicado: (2012)

Loganin Inhibits Angiotensin II–Induced Cardiac Hypertrophy Through the JAK2/STAT3 and NF-κB Signaling Pathways
por: Xu, Jia-jia, et al.
Publicado: (2021)

Hydroxysafflor yellow A protects against angiotensin II-induced hypertrophy
por: Ni, Bin, et al.
Publicado: (2018)

Effectiveness of Some Vitamins in the Prevention of Cardiovascular Disease: A Narrative Review
por: Shah, Anureet K., et al.
Publicado: (2021)

Angiotensin-Converting Enzyme 2 Over-Expression in the Central Nervous System Reduces Angiotensin-II-Mediated Cardiac Hypertrophy
por: Feng, Yumei, et al.
Publicado: (2012)

Involvement of Oxidative Stress in the Development of Subcellular Defects and Heart Disease
por: Dhalla, Naranjan S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_43h1l32htflbqkgc9l9u6oaals